The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1229
February 27, 2006
View Complete Issue         Table of Contents 2019 
Coenzyme Q10
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
Coenzyme Q10
February 27, 2006 (Issue: 1229)
Coenzyme Q10, a fat-soluble antioxidant also known as ubidecarenone, ubiquinone and CoQ10, is marketed as a dietary supplement in the US, both as a single ingredient and in various combination products.
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App
  • FREE online per issue CME/CE
Purchase this article:
Title: Coenzyme Q10
Article code: 1229b
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.